158
Participants
Start Date
March 31, 2002
Primary Completion Date
June 30, 2005
gefitinib
Given PO
radiation therapy
Undergo radiation therapy
laboratory biomarker analysis
Correlative studies
Radiation Therapy Oncology Group, Philadelphia
Collaborators (1)
NRG Oncology
OTHER
National Cancer Institute (NCI)
NIH